Microglial NADPH oxidase mediates leucine enkephalin dopaminergic neuroprotection

Annals of the New York Academy of Sciences

Volumn 1053, Issue , 2005, Pages 107-120

  Qin, Liya ^a   Liu, Yuxin ^a,b   Qian, Xun ^a   Hong, Jau Shyong ^a   Block, Michelle L ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Des tyrosine leucine enkephalin (DTLE); Leucine enkephalin (LE); Lipopolysaccharide (LPS); Microglial NADPH oxidase; Neuroprotection; Neurotoxicity; Tumor necrosis factor alpha (TNF )

Indexed keywords

DOPAMINE; GLYCYLGLYCYLPHENYLALANYLLEUCINE; KAPPA OPIATE RECEPTOR; LEUCINE ENKEPHALIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 29744453873     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1344.009     Document Type: Conference Paper

References (45)

1. MCGEER, P.L. & E. MCGEER. 2004. Immunotherapy for Alzheimer's disease. Sci. Aging Knowledge Environ. 2004: PE29.
2. SCHOFIELD, E. et al. 2003. Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders. Brain 126: 827-840.
3. CHAVARRIA, A. & J. ALCOCER-VARELA. 2004. Is damage in central nervous system due to inflammation? Autoimmun. Rev. 3: 251-260.
4. MCGEER, P.L. et al. 1988. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285-1291.
5. MCGEER, P.L. & E.G. MCGEER. 2004. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 10(suppl. 1): S3-S7.
6. LIU, B. & J.S. HONG. 2003. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304: 1-7.
7. LIU, B. et al. 2001. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J. Pharmacol. Exp. Ther. 298: 1133-1141.
8. QIN, L. et al. 2005. Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J. 19: 550-557.
9. LOEFFLER, D.A. et al. 1994. Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation. Clin. Neuropharmacol. 17: 370-379.
10. CARVEY, P.M. et al. 2003. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front. Biosci. 8: s826-s837.
11. GAO, H.M. et al. 2002. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81: 1285-1297.
12. GAYLE, D.A. et al. 2002. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res. Dev. Brain Res. 133: 27-35.
13. KIM, W.G. et al. 2000. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20: 6309-6316.
14. WIEDERMANN, F.J. et al. 2002. Migration of human monocytes in response to procalcitonin. Crit. Care Med. 30: 1112-1117.
15. GRUBER, B.L., M.J. MARCHESE & R. KEW. 1995. Angiogenic factors stimulate mast-cell migration. Blood 86: 2488-2493.
16. WILLIAMSON, S.A. et al. 1987. Differential effects of beta-endorphin fragments on human natural killing. Brain Behav. Immun. 1: 329-335.
17. WILLIAMSON, S.A. et al. 1988. Effects of beta endorphin on specific immune responses in man. Immunology 65: 47-51.
18. DAS, K.P. et al. 1995. Modulatory effects of [Met5]-enkephalin on interleukin-1 beta secretion from microglia in mixed brain cell cultures. J. Neuroimmunol. 62: 9-17.
19. FAITH, R.E. et al. 1984. Neuroimmunomodulation with enkephalins: enhancement of human natural killer (NK) cell activity in vitro. Clin. Immunol. Immunopathol. 31: 412-418.
20. SOWA, G. et al. 1997. Inhibition of swine microglial cell phagocytosis of Cryptococcus neoformans by femtomolar concentrations of morphine. Biochem. Pharmacol. 53: 823-828.
21. GLADYSHEVA, T.B., A.A. KONRADOV & K.A. LEBEDEV. 1989. The dose dependence of various loads using the rosette formation method. Biofizika 34: 833-834.
22. DELGADO, M. et al. 1999. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6. J. Immunol. 162: 1200-1205.
23. KONG, L.Y. et al. 1999. Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide. Neuroscience 91: 493-500.
24. GOZES, I. et al. 1999. A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein. Ann. N.Y. Acad. Sci. 897: 125-135.
25. KONG, L.Y. et al. 2000. Reduction of lipopolysaccharide-induced neurotoxicity in mouse mixed cortical neuron/glia cultures by ultralow concentrations of dynorphins. J. Biomed. Sci. 7: 241-247.
26. LIU, B. et al. 2000. Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 97: 749-756.
27. QIN, L. et al. 2004. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 279: 1415-1421.
28. PESKIN, A.V. & C.C. WINTERBOURN. 2000. A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1). Clin. Chim. Acta 293: 157-166.
29. LIU, B. & J.S. HONG. 2003. Primary rat mesencephalic neuron-glia, neuron-enriched, microglia-enriched, and astroglia-enriched cultures. Methods Mol. Med. 79: 387-395.
30. TAN, A.S. & M.V. BERRIDGE. 2000. Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1, to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J. Immunol. Methods 238: 59-68.
31. WALKER, N.J. 2001. Real-time and quantitative PCR: applications to mechanism-based toxicology. J. Biochem. Mol. Toxicol. 15: 121-127.
32. LIU, B., L. DU & J.S. HONG. 2000. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther. 293: 607-617.
33. LI, G. et al. 2005. Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage. FASEB J. 19: 489-496.
34. BRENNEMAN, D.E. & I. GOZES. 1996. A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97: 2299-2307.
35. GOZES, I. & D.E. BRENNEMAN. 1996. Activity-dependent neurotrophic factor (ADNF): an extracellular neuroprotective chaperonin? J. Mol. Neurosci. 7: 235-244.
36. GOZES, I. et al. 1996. Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA 93: 427-432.
37. ARIMURA, A. et al. 1994. PACAP functions as a neurotrophic factor. Ann. N.Y. Acad. Sci. 739: 228-243.
38. GOZES, I. et al. 2000. A novel VIP responsive gene: activity dependent neuroprotective protein. Ann. N.Y. Acad. Sci. 921: 115-118.
39. BURRITT, J.B. et al. 2003. Functional epitope on human neutrophil flavocytochrome b558. J. Immunol. 170: 6082-6089.
40. WU, D.C. et al. 2003. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 100: 6145-6150.
41. WU, X. et al. 2005. The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid. Redox Signal. 7: 645-651.
42. BLOCK, M.L. et al. 2004. Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J. 18: 1618-1620.
43. QIN, L. et al. 2002. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83: 973-983.
44. GAO, H.M. et al. 2002. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 22: 782-790.
45. GAO, H.M. et al. 2003. Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. FASEB J. 17: 1957-1959.